Pfizer has informed that Pfizer (‘the Company’) has entered into an exclusive Supply and Marketing Agreement with Cipla for marketing and distribution of four brands of the Company, Corex Dx, Corex LS, Dolonex, and Neksium for an initial period of 5 years. The additional details required to be disclosed, pursuant to the Listing Regulations read with the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure A. The joint Press Release issued by Pfizer and Cipla in this regard is enclosed as Annexure B.
The above information is a part of company’s filings submitted to BSE.
